NewAmsterdam Pharma Company N.V. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
NAMS Nasdaq 2830 www.newamsterdampharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 6th, 2026 2:01 pm
NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears - Aug 5th, 2026 11:04 am
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Lags Revenue Estimates - Aug 5th, 2026 7:55 am
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - Aug 5th, 2026 5:00 am
NewAmsterdam Pharma to Host Investor Day on August 5, 2026 - Jul 29th, 2026 6:00 am
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination) - Jul 24th, 2026 6:00 am
Attovia Therapeutics Appoints John W. Smither to Board of Directors - Jul 15th, 2026 6:30 am
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma - Jul 7th, 2026 6:00 am
NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026 - Jul 1st, 2026 6:00 am
A Look At NewAmsterdam Pharma (NAMS) Valuation After Recent Share Price Weakness - Jun 11th, 2026 4:11 am
Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026 - Jun 8th, 2026 8:29 am
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions - Jun 3rd, 2026 6:00 am
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge - May 30th, 2026 12:12 pm
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean - May 30th, 2026 10:48 am
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June - May 28th, 2026 6:00 am
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - May 11th, 2026 10:37 am
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May - May 11th, 2026 6:41 am